DK105921C - Fremgangsmåde til stabilisering af cycloheximid. - Google Patents

Fremgangsmåde til stabilisering af cycloheximid.

Info

Publication number
DK105921C
DK105921C DK87163AA DK87163A DK105921C DK 105921 C DK105921 C DK 105921C DK 87163A A DK87163A A DK 87163AA DK 87163 A DK87163 A DK 87163A DK 105921 C DK105921 C DK 105921C
Authority
DK
Denmark
Prior art keywords
cycloheximide
stabilizing
stabilizing cycloheximide
Prior art date
Application number
DK87163AA
Other languages
English (en)
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK105921C publication Critical patent/DK105921C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK87163AA 1962-02-26 1963-02-26 Fremgangsmåde til stabilisering af cycloheximid. DK105921C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US175795A US3092546A (en) 1962-02-26 1962-02-26 Antifungal cycloheximide starch inclusion compositions

Publications (1)

Publication Number Publication Date
DK105921C true DK105921C (da) 1966-11-28

Family

ID=22641660

Family Applications (1)

Application Number Title Priority Date Filing Date
DK87163AA DK105921C (da) 1962-02-26 1963-02-26 Fremgangsmåde til stabilisering af cycloheximid.

Country Status (2)

Country Link
US (1) US3092546A (da)
DK (1) DK105921C (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4297339A (en) * 1979-06-18 1981-10-27 The Upjohn Company Controlled release cycloheximide compositions
DE19751630A1 (de) * 1997-11-21 1999-05-27 Bayer Ag Inklusionskomplexe aus modifizierten Kohlenhydraten und agrochemischen Wirkstoffen
KR101025612B1 (ko) * 2008-11-10 2011-03-30 한국해양연구원 신규 화합물인 Ｒａｍａｌｉｎ 및 그 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2614945A (en) * 1949-09-14 1952-10-21 George A Krisan Method of making mobile starch powders
US2613206A (en) * 1949-12-14 1952-10-07 Nat Starch Products Inc Free-flowing starch esters
US2876160A (en) * 1954-07-26 1959-03-03 Corn Prod Refining Co Starch matrix material containing imbedded material and process for preparing same
US2786011A (en) * 1954-06-18 1957-03-19 Ohio Commw Eng Co Stable concentrated aqueous dispersion of pesticides and the like
US2913372A (en) * 1954-07-23 1959-11-17 Atlas Powder Co Compositions for dispersing powders in water
US2876165A (en) * 1954-08-03 1959-03-03 Ohio Commw Eng Co Dusting powder including salts of carboxymethyl dextran
US2827452A (en) * 1955-05-31 1958-03-18 Univ Minnesota Stabilization of materials
US2956922A (en) * 1955-12-05 1960-10-18 Merck & Co Inc Protection of growing plants
US2861024A (en) * 1957-11-12 1958-11-18 Merck & Co Inc Antibiotic dusts
US2992161A (en) * 1958-01-20 1961-07-11 Du Pont Zinc ethylene bis (dithiocarbamate) compositions
US2887433A (en) * 1958-04-18 1959-05-19 Upjohn Co Fungicidal composition comprising cycloheximide and pentachloronitrobenzene
US3025217A (en) * 1958-05-28 1962-03-13 Olin Mathieson Dry amylopectin therapeutic dusting powders
US2997423A (en) * 1959-04-20 1961-08-22 Ohio Commw Eng Co Method of making a composition of sodium carboxymethyl dextran and an antibiotic

Also Published As

Publication number Publication date
US3092546A (en) 1963-06-04

Similar Documents

Publication Publication Date Title
DK116935B (da) Fremgangsmåde til fremstilling af små kapsler.
DK115403B (da) Fremgangsmåde til fremstilling af (3-amino-pyrazinoyl)-guanidiner.
DK117953B (da) Analogifremgangsmåde til fremstilling af p-aminoalkoxyphenylalkenderivater.
DK104675C (da) Fremgangsmåde til fremstilling af 3-hydroxy-N-nitro-picolinamid.
DK115325B (da) Fremgangsmåde til fremstilling af fenylalkylsulfamider.
DK105921C (da) Fremgangsmåde til stabilisering af cycloheximid.
DK105647C (da) Fremgangsmåde til fremstilling af alkylsubstituerede 3-amino-isoxazoler.
DK103476C (da) Fremgangsmåde til fremstilling af 2-oxa-3-oxo-steroider.
DK103512C (da) Fremgangsmåde til fremstilling af 3-nitroso-2-oxazolidon.
DK108915C (da) Fremgangsmåde til fremstilling af 21-acyloxy-acetyloxy-corticosteroider.
DK119354B (da) Fremgangsmåde til fremstilling af 3-sulfamoyl-5-tert.-aminopropyliden-5H-dibenzo-[a,d]-cycloheptener.
DK109324C (da) Fremgangsmåde til fremstilling af 1-brom-chlor-2,2-difluorpropan.
DK104063C (da) Fremgangsmåde til fremstilling af 4-hydroxy-5-halogenpyrimidiner.
DK115620B (da) Fremgangsmåde til fremstilling af 17α-klorætynyl-17βalkoksysteroider.
DK113647B (da) Fremgangsmåde til fremstilling af 2-sulfanilamido-5-metoxypyrimidin.
DK102920C (da) Fremgangsmåde til fremstilling af 1-cyancolchicinderivater.
DK106337C (da) Fremgangsmåde til fremstilling af 3α-phenylgranatanderivater.
DK123593B (da) Fremgangsmåde til stabilisering af α-azidocarbonylforbindelser.
DK106330C (da) Fremgangsmåde til fremstilling af 16-halogenmethylen-17α-hydroxy-3,20-diketo-4,6-pregnadienderivater.
DK108027C (da) Fremgangsmåde til fremstilling af glucuronamider.
DK103833C (da) Fremgangsmåde til fremstilling af desacetylamino-N-methylcolchiceinamid.
DK108624C (da) Fremgangsmåde til fremstilling af 1α-metylcorticoider.
DK108795C (da) Fremgangsmåde til fremstilling af 2-ureido-2-furanacetonitril.
DK104621C (da) Fremgangsmåde til fremstilling af monooxymethylcyclooctan.
DK105463C (da) Fremgangsmåde til fremstilling af 10-alkyl-3-keto-steroider.